Andere Sprachen Achieve Life Sciences, Inc.

Aktien

A2QAR3

US0044685008

ACHV

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
4,61 ^USD	+0,77 %		+2,22 %	+11,89 %

17.04.	ACHIEVE LIFE SCIENCES, INC. : Von JonesTrading Institutional Services zum Kauf angehoben	ZM
28.03.	Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024	25.04.
Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference	11.04.
Achieve Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update	28.03.
Achieve Life Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.03.
Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting	20.03.
Achieve Life Sciences, Inc. Announces Data from Cytisinicline ORCA Program to Be Presented at the 2024 Society for Research on Nicotine and Tobacco Annual Meeting	20.03.
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024	14.03.
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	06.03.
Sector Update: Health Care Stocks Decline Late Afternoon	29.02.
Sector Update: Health Care	29.02.
Achieve Life Sciences Agrees on Safety Exposure Data for Smoking Cessation Medication as Part of NDA	29.02.
Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA Submission	29.02.
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement	29.02.
Top Midday Decliners	12.12.
Wall Street Set to Open Slightly Higher Tuesday; Annual Inflation Declines to 3.1%	12.12.
Investors Await Inflation Data, Look to Last Fed Meeting of Year as US Futures Rise Slightly in Tuesday's Premarket	12.12.
Top Premarket Decliners	12.12.
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	11.12.
Achieve Life Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Achieve Life Sciences, Inc.

Aktien

A2QAR3

US0044685008

ACHV

Andere Sprachen

Filter